[HTML][HTML] Tuberculosis and COVID-19 interaction: a review of biological, clinical and public health effects
Evidence is accumulating on the interaction between tuberculosis (TB) and COVID-19. The
aim of the present review is to report the available evidence on the interaction between …
aim of the present review is to report the available evidence on the interaction between …
Myocarditis is rare in COVID-19 autopsies: cardiovascular findings across 277 postmortem examinations
The COVID-19 pandemic, the result of severe acute respiratory syndrome (SARS)-CoV-2, is
a major cause of worldwide mortality with a significant cardiovascular component. While a …
a major cause of worldwide mortality with a significant cardiovascular component. While a …
COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects
DM Smadja, SJ Mentzer, M Fontenay, MA Laffan… - Angiogenesis, 2021 - Springer
Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with …
syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with …
[HTML][HTML] Cardiovascular complications of COVID-19
The emergence of the novel SARS coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), has resulted in an unprecedented pandemic that has …
coronavirus disease 2019 (COVID-19), has resulted in an unprecedented pandemic that has …
Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis
The pathogenesis of SARS-CoV-2 remains to be completely understood, and detailed SARS-
CoV-2 cellular cytopathic effects requires definition. We performed a comparative …
CoV-2 cellular cytopathic effects requires definition. We performed a comparative …
COVID-19 and the vasculature: current aspects and long-term consequences
B Martinez-Salazar, M Holwerda, C Stuedle… - Frontiers in cell and …, 2022 - frontiersin.org
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was first identified in
December 2019 as a novel respiratory pathogen and is the causative agent of Corona Virus …
December 2019 as a novel respiratory pathogen and is the causative agent of Corona Virus …
Postmortem findings associated with SARS-CoV-2: systematic review and meta-analysis
Abstract Coronavirus Disease 2019 (COVID-19), caused by the novel Severe Acute
Respiratory Syndrome–associated Coronavirus 2 (SARS-CoV-2), has become a global …
Respiratory Syndrome–associated Coronavirus 2 (SARS-CoV-2), has become a global …
Impact of COVID-19 on cardiovascular disease
Coronavirus disease 2019 (COVID-19) is a viral infection with the novel severe acute
respiratory distress syndrome corona virus 2 (SARS-CoV-2). Until now, more than 670 …
respiratory distress syndrome corona virus 2 (SARS-CoV-2). Until now, more than 670 …
SARS-CoV-2 induces lymphocytopenia by promoting inflammation and decimates secondary lymphoid organs
Q **ang, Z Feng, B Diao, C Tu, Q Qiao, H Yang… - Frontiers in …, 2021 - frontiersin.org
While lymphocytopenia is a common characteristic of coronavirus disease 2019 (COVID-
19), the mechanisms responsible for this lymphocyte depletion are unclear. Here, we …
19), the mechanisms responsible for this lymphocyte depletion are unclear. Here, we …
Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy
MJ McConnell, N Kawaguchi, R Kondo, A Sonzogni… - Journal of …, 2021 - Elsevier
Background and Aims COVID-19 is associated with liver injury and elevated interleukin-6 (IL-
6). We hypothesized that IL-6 trans-signaling in liver sinusoidal endothelial cells (LSECs) …
6). We hypothesized that IL-6 trans-signaling in liver sinusoidal endothelial cells (LSECs) …